DAIREI CO.,LTD.
2883・Standard Market・Foods
Business
Dairei Co., Ltd. was established in 1972 as a company specializing in the wholesale of commercial-use frozen foods. Its main customers are end users in the medical food, nursing care food, boxed meal catering, and food service sectors. The company operates on a fabless model, holding no manufacturing facilities of its own and instead outsourcing production to partner factories in Japan and overseas (China, Vietnam, and Thailand). Its core "Honeless Fish" business was independently developed in 1998, and the company holds four manufacturing patents related to it. The company consists of three business segments: the Boneless Fish business, the Meat business, and Other businesses (cooked frozen foods, marine products, etc.). It has built a nationwide branch network combined with external logistics to enable next-day delivery starting from a single case. The company is listed on the Standard Market of the Tokyo Stock Exchange.
Business Model
The company concentrates its management resources on product planning/development and sales, outsourcing manufacturing to partner factories both domestic and overseas, and outsourcing warehousing/logistics to external vendors, adopting a fully fabless wholesale model. In addition to its own branded products, it also handles PB (private brand) products, continuously updating its product lineup through monthly new-product selection via special product development projects and a final selection meeting held twice a year. The structure aims to generate earnings through product development capability and a nationwide sales network while minimizing the fixed-cost burden of manufacturing equipment.
Company Strengths
In 1998, the company succeeded in developing boneless fish and acquired four manufacturing patents, including for a "method of manufacturing heat-treated fish." It has introduced X-ray residual bone inspection and a boneless fish information traceability system, and as of March 2026 handles 32 fish species. It has established technological superiority over competitors by developing differentiated product lines such as "Rakuraku Cook," which can be cooked directly from frozen and retains its softness even after cooling.
The company does not own manufacturing facilities itself, adopting a fabless business model in which manufacturing is outsourced to partner factories in Japan and overseas. Capital expenditure was extremely minimal at ¥31,323 thousand for FY2026 (ending March 2026), resulting in a low fixed cost burden. While maintaining quality control by requiring resident Japanese staff and rotating personnel at overseas partner factories, the company has secured procurement cost competitiveness by diversifying production bases to countries such as Thailand and Vietnam.
Since its founding in 1972, the company has established branches in Sendai, Osaka, Nagoya, Fukuoka, Hiroshima, Sapporo, and Takasaki, building a nationwide sales and distribution network. Through a cargo storage and transport agreement with an external logistics provider (Hi-Tech Noorin Co., Ltd.), the company has achieved next-day delivery starting from a single case, contributing to improved convenience for diverse end users, including in the medical and food service industries.
ENVALITH's Perspective
Performance Trend
Revenue peaked at ¥27,240 million in FY2023 (ended March 2023) and declined for three consecutive fiscal years, reaching ¥25,053 million in FY2026 (ending March 2026), down 2.6% year on year. Operating profit also fell from ¥1,525 million in FY2023 (ended March 2023) to ¥660 million in FY2026 (ending March 2026), the lowest level in the past five fiscal years. External factors—sustained high raw material and energy prices, rising procurement costs due to foreign exchange movements, and the spread of consumer thrift sentiment—weighed on earnings. On the other hand, the disappearance of the prior-period business restructuring loss (¥1,129 million) enabled net income to turn positive at ¥482 million. Operating cash flow fell sharply to ¥309 million (from ¥710 million in the prior period), raising concerns about declining cash-generating capacity. The equity ratio remained solid at 78.0%, indicating financial health was maintained.
Growth Strategy
The company aims to achieve increased sales and profit by reconstructing the boneless fish business through expanded sales of the new "MOTTO" series and diversified production
The company aims to reconstruct the boneless fish business by expanding sales of the new "MOTTO" series, which offers improved taste at low prices in response to consumers' savings-oriented mindset, and by expanding sales of cooked and processed products. Boneless fish business sales for FY2027 (ending March 2027) are projected at ¥8,834 million (up 1.4% year on year).
Sales growth is expected through expanded sales of low-priced, price-competitive Thailand-produced "Rakuraku Shomi" chicken products. Meat business sales for FY2027 (ending March 2027) are projected at ¥2,473 million (up 1.3% year on year). Sales of American dog-type products continue to recover, and the foundation for growth is steadily being established.
The company will continue to aim for sales growth of oyster and shrimp products launched in the previous fiscal year, while also introducing new low-priced products to the market. Other business sales for FY2027 (ending March 2027) are projected to remain at the previous year's level of ¥13,892 million. Gross margin improvement is expected as the prior-period loss related to Vietnamese shrimp is resolved.
The company is leveraging the fact that approximately 60% of its partner factories are located overseas to promote direct trade and reduce procurement costs. The foreign exchange assumption is 1 US dollar = ¥160. The company will continue working to reduce procurement costs and aims to improve gross margin, combined with increased rebates from achieving annual contract targets.
Last updated: July 19, 2026